Accelerating HCP engagement in Singapore using customer reference data
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

24

Sep 2021

Amnio Technology Awarded U.S. Patent for Amniotic Allografts

Amnio Technology LLC a global leader in the development and distribution of amniotic tissue allografts is announcing today that the United States Patent and Trademark Office has issued a new patent titled Enriched Multilayer Amnion Derived Tissue Graft The new patent strengthens Amnio Technologys in...

24

Sep 2021

Phenomenex Announces the Release of New Biozen® SEC Size Exclusion Chromatography Columns

Phenomenex Inc a global leader in the research and manufacture of advanced technologies for the separation sciences announces the successful launch of NEW Biozen SEC Size Exclusion Chromatography Columns to the existing Biozen portfolio of biological workflow products for the analysis of monoclonal...

23

Sep 2021

Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster

Pfizer Inc and BioNTech SE announced that the US Food and Drug Administration FDA has authorized for emergency use a booster dose of the PfizerBioNTech COVID Vaccine for individuals years of age and older individuals through years of age at high risk of severe COVID and individuals through year...

23

Sep 2021

AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies

AbCellera and Everest Medicines Limited announced that they have entered into a multiyear collaboration and license agreement to discover therapeutic antibodies for up to targets selected by Everest The partnership will help to expand Everests portfolio of novel medicines across multiple indication...

press releasesRead more...

24

Sep 2021

Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia announced today that the Center for Drug Evaluation CDE of the National Medical Products Administration NMPA o...

23

Sep 2021

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity

AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery development and commercialisastion of the proprietary selfamplifying RNA saRNA therapeutics platform developed at Imperial College London The strategic longterm research collaboration aims to optimise and validate V...

23

Sep 2021

Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics

Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced it has expanded its research collaboration with Columbia University The research collaboration is focused on studying immune responses to COVID in healthy volunteers who have recovered from COVID or were asy...

23

Sep 2021

Quell Therapeutics Significantly Expands Clinical Manufacturing Capacity for its Engineered Treg Cell Therapies through a Collaboration with the Cell and Gene Therapy Catapult

Quell Therapeutics Ltd Quell the world leader in developing engineered Tregulatory Treg cell therapies for serious medical conditions driven by the immune system today announced it has entered a collaboration with the Cell and Gene Therapy Catapult CGT Catapult The collaboration will expand Quells c...

EventsRead more...

27 - 28

Sep 2021

27 - 28

Sep 2021

29 - 30

Sep 2021

TOP ARTICLES

  • 2

    Artificial Intelligence

    Artificial Intelligence AI is a field of computer science that studies how machines imitate the intelligence o...
  • 3

    Homeopathic Science

    Homeopathy a controversial medical system discovered by a German physician Samuel Hahnemann was first postula...

KNOWLEDGE BANK

  • Interviews

    European Lead Factory

    Head of European Screening Centre

    Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature
  • Articles

    A Structured Review on BCRP-Mediated Multidrug Resistance

    Many of the human ABC proteins are efflux transporters and three of them namely Pglycoprotein Pgp gene symbol ABCB the multidrug resistance protein MRP gene symbol ABCC and the breast cancer resistance protein BCRP gene symbol ABCG have been implicated to be the major efflux transporters responsible for multidrug resistance in cancer cells

  • Case Studies

    Ambient Stable Biologics - Stable Aqueous Erythropoietin

    Challenge Erythropoietin EPO is known to aggregate under heat stress which prevents storage of liquid compositions at ambient temperature The key challenge of this study was to demonstrate that the application of the ArestatT tools can reduce significantly aggregation of EPO at an elevated temperature compared with a marketed liquid formulation

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...